Integral Health Asset Management’s Sana Biotechnology SANA Stock Holding History

Integral Health Asset Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.98M	Sell	2,000,000 -1,200,000	-38%	-$3.87M	0.28%	71
2026 Q1	$9.22M	Buy	3,200,000 +200,000	+7%	+$788K	0.44%	62
2025 Q4	$12.2M	Buy	3,000,000 +1,000,000	+50%	+$4.48M	0.61%	53
2025 Q3	$7.1M	Buy	2,000,000 +500,000	+33%	+$1.81M	0.48%	63
2025 Q2	$4.09M	Sell	1,500,000 -500,000	-25%	-$1.03M	0.37%	61
2025 Q1	$3.36M	Hold	2,000,000	–	–	0.36%	65
2024 Q4	$3.26M	Buy	2,000,000 +200,000	+11%	+$596K	0.28%	71
2024 Q3	$7.49M	Buy	1,800,000 +600,000	+50%	+$3.15M	0.84%	32
2024 Q2	$6.55M	Buy	1,200,000 +220,000	+22%	+$1.75M	0.62%	47
2024 Q1	$9.8M	Buy	+980,000	New	+$7.34M	0.91%	43

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Integral Health Asset Management's SANA Position: Q2 2026 in Review

Integral Health Asset Management reduced its Sana Biotechnology (SANA) stake by 38% in Q2 2026, selling an estimated $3.87M and leaving 2,000,000 shares worth $6.98M. The position accounts for 0.28% of the portfolio, ranked #71.

Integral Health Asset Management first reported a position in SANA in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.2M in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Integral Health Asset Management held 2,000,000 shares of Sana Biotechnology worth $6.98M as of Q2 2026.
Integral Health Asset Management sold 1,200,000 Sana Biotechnology shares in Q2 2026, an estimated $3.87M.
Sana Biotechnology made up 0.28% of Integral Health Asset Management's portfolio in Q2 2026, its #71 holding.
Integral Health Asset Management first reported a position in Sana Biotechnology in Q1 2024 and has held it in 10 quarters since.
Integral Health Asset Management's Sana Biotechnology position peaked at $12.2M in Q4 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.